S Y Amy Cheung

23PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsSolid tumoursEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 02, 2026
Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.

John F R Robertson, Teimuraz Gogitidze, Zaza Katashvili

|Dec 18, 2025
Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.

Antonio J Esgueva, Mariano Tomatis, Antonio Ponti

|Sep 30, 2025
Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis.

Yubo Wang, Li-Chia Chen, Kwok-Leung Cheung

|Jul 23, 2025
The Association Between Psychosocial Factors and Decision Making Regarding Primary Treatment in Older Women With Early-Stage Breast Cancer.

G Hindler, I Alabaster, R Zahit

|Feb 13, 2025
Updates and Future Directions for the Nottingham Research Programme on Primary Breast Cancer in Older Women.

Ruth Mary Parks, Kwok-Leung Cheung

|Feb 24, 2024
Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels.

Yubo Wang, Douglas Steinke, Sean P Gavan

Pageof 4

Frequent Collaborators

9 joint publications

Ruth Parks

4 joint publications

Sean P Gavan

4 joint publications

Douglas Steinke

4 joint publications

Justin P O Lindemann